Vaccines against Coronaviruses: The State of the Art

The emerging epidemic caused by the new coronavirus SARS-CoV-2 represents the most important socio-health threat of the 21st century. The high contagiousness of the virus, the strong impact on the health system of the various countries and the absence to date of treatments able to improve the progno...

Full description

Bibliographic Details
Main Authors: Cristiano Conte, Francesco Sogni, Paola Affanni, Licia Veronesi, Alberto Argentiero, Susanna Esposito
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/8/2/309
_version_ 1827714895224766464
author Cristiano Conte
Francesco Sogni
Paola Affanni
Licia Veronesi
Alberto Argentiero
Susanna Esposito
author_facet Cristiano Conte
Francesco Sogni
Paola Affanni
Licia Veronesi
Alberto Argentiero
Susanna Esposito
author_sort Cristiano Conte
collection DOAJ
description The emerging epidemic caused by the new coronavirus SARS-CoV-2 represents the most important socio-health threat of the 21st century. The high contagiousness of the virus, the strong impact on the health system of the various countries and the absence to date of treatments able to improve the prognosis of the disease make the introduction of a vaccine indispensable, even though there are currently no approved human coronavirus vaccines. The aim of the study is to carry out a review of the medical literature concerning vaccine candidates for the main coronaviruses responsible for human epidemics, including recent advances in the development of a vaccine against COVID-19. This extensive review carried out on the vaccine candidates of the main epidemic coronaviruses of the past has shown that the studies in animal models suggest a high efficacy of potential vaccines in providing protection against viral challenges. Similar human studies have not yet been carried out, as the main trials are aimed at assessing mainly vaccine safety and immunogenicity. Whereas the severe acute respiratory syndrome (SARS-CoV) epidemic ended almost two decades ago and the Middle East respiratory syndrome (MERS-CoV) epidemic is now better controlled, as it is less contagious due to the high lethality of the virus, the current SARS-CoV-2 pandemic represents a problem that is certainly more compelling, which pushes us to accelerate the studies not only for the production of vaccines but also for innovative pharmacological treatments. SARS-CoV-2 vaccines might come too late to affect the first wave of this pandemic, but they might be useful if additional subsequent waves occur or in a post-pandemic perspective in which the virus continues to circulate as a seasonal virus.
first_indexed 2024-03-10T19:06:54Z
format Article
id doaj.art-33b3fe95881c4de1bf150fc5070838ed
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T19:06:54Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-33b3fe95881c4de1bf150fc5070838ed2023-11-20T04:04:30ZengMDPI AGVaccines2076-393X2020-06-018230910.3390/vaccines8020309Vaccines against Coronaviruses: The State of the ArtCristiano Conte0Francesco Sogni1Paola Affanni2Licia Veronesi3Alberto Argentiero4Susanna Esposito5Pediatric Clinic, Department of Medicine and Surgery, Pietro Barilla Children’s Hospital, University of Parma, 43126 Parma, ItalyPediatric Clinic, Department of Medicine and Surgery, Pietro Barilla Children’s Hospital, University of Parma, 43126 Parma, ItalyDepartment of Medicine and Surgery, University of Parma, 43126 Parma, ItalyDepartment of Medicine and Surgery, University of Parma, 43126 Parma, ItalyPediatric Clinic, Department of Medicine and Surgery, Pietro Barilla Children’s Hospital, University of Parma, 43126 Parma, ItalyPediatric Clinic, Department of Medicine and Surgery, Pietro Barilla Children’s Hospital, University of Parma, 43126 Parma, ItalyThe emerging epidemic caused by the new coronavirus SARS-CoV-2 represents the most important socio-health threat of the 21st century. The high contagiousness of the virus, the strong impact on the health system of the various countries and the absence to date of treatments able to improve the prognosis of the disease make the introduction of a vaccine indispensable, even though there are currently no approved human coronavirus vaccines. The aim of the study is to carry out a review of the medical literature concerning vaccine candidates for the main coronaviruses responsible for human epidemics, including recent advances in the development of a vaccine against COVID-19. This extensive review carried out on the vaccine candidates of the main epidemic coronaviruses of the past has shown that the studies in animal models suggest a high efficacy of potential vaccines in providing protection against viral challenges. Similar human studies have not yet been carried out, as the main trials are aimed at assessing mainly vaccine safety and immunogenicity. Whereas the severe acute respiratory syndrome (SARS-CoV) epidemic ended almost two decades ago and the Middle East respiratory syndrome (MERS-CoV) epidemic is now better controlled, as it is less contagious due to the high lethality of the virus, the current SARS-CoV-2 pandemic represents a problem that is certainly more compelling, which pushes us to accelerate the studies not only for the production of vaccines but also for innovative pharmacological treatments. SARS-CoV-2 vaccines might come too late to affect the first wave of this pandemic, but they might be useful if additional subsequent waves occur or in a post-pandemic perspective in which the virus continues to circulate as a seasonal virus.https://www.mdpi.com/2076-393X/8/2/309coronavirusMERSpandemicSARSSARS-CoV-2vaccine candidate
spellingShingle Cristiano Conte
Francesco Sogni
Paola Affanni
Licia Veronesi
Alberto Argentiero
Susanna Esposito
Vaccines against Coronaviruses: The State of the Art
Vaccines
coronavirus
MERS
pandemic
SARS
SARS-CoV-2
vaccine candidate
title Vaccines against Coronaviruses: The State of the Art
title_full Vaccines against Coronaviruses: The State of the Art
title_fullStr Vaccines against Coronaviruses: The State of the Art
title_full_unstemmed Vaccines against Coronaviruses: The State of the Art
title_short Vaccines against Coronaviruses: The State of the Art
title_sort vaccines against coronaviruses the state of the art
topic coronavirus
MERS
pandemic
SARS
SARS-CoV-2
vaccine candidate
url https://www.mdpi.com/2076-393X/8/2/309
work_keys_str_mv AT cristianoconte vaccinesagainstcoronavirusesthestateoftheart
AT francescosogni vaccinesagainstcoronavirusesthestateoftheart
AT paolaaffanni vaccinesagainstcoronavirusesthestateoftheart
AT liciaveronesi vaccinesagainstcoronavirusesthestateoftheart
AT albertoargentiero vaccinesagainstcoronavirusesthestateoftheart
AT susannaesposito vaccinesagainstcoronavirusesthestateoftheart